BIOTEST ApS: Financial statements 2023
CVR: 26736994
Source: annual report 2023, Danish Business Authority
01/01/2023 – 31/12/2023
BIOTEST ApS (CVR 26736994) has filed annual accounts for 2023. In 2023, the company reported a gross profit of DKK -37,742 and a net result of DKK 240,932 compared with DKK -390,731 the year before. Equity in the 2023 report amounted to DKK 1,256,918. The solvency ratio was 80.6%.
- Gross Profit
- DKK -37,742
- Profit/Loss
- DKK 240,932
- Equity
- DKK 1,256,918
- Total Assets
- DKK 1,560,329
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2023 | - | -38 t. | 241 t. | 1.3 mio. | - |
| 2022 | - | -36 t. | -391 t. | 1 mio. | 1 |
| 2021 | - | 272 t. | 127 t. | 1.5 mio. | 1 |
| 2020 | - | 399 t. | 280 t. | 1.5 mio. | 1 |
| 2019 | - | 79 t. | 263 t. | 1.3 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2023
BIOTEST ApS has published its annual report for 2022. Gross profit came to DKK -35,550, and the net result was DKK -390,731.
About BIOTEST ApS
BIOTEST ApS is a Danish company of the type Anpartsselskab based in Middelfart, founded in 2002. The company is registered under the industry Anden måling og teknisk analyse. The management consists of Pauli Lejf Kiel. The company is owned by Pauli Lejf Kiel. The company has 1 employee (2018). In 2025, the company reported a gross profit of DKK -54,968 and a net result of DKK -65,376 compared with DKK 100,748 the year before. Equity in the 2025 report amounted to DKK 1,035,290.